Search Results - Andre Lieber
- Showing 1 - 16 results of 16
-
1
-
2
CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cel... by Hongjie Wang, Theo Koob, Jonathan R. Fromm, Ajay Gopal, Darrick Carter, André Lieber
Published in Cancer Biology & Therapy (2024-12-01)Get full text
Article -
3
-
4
HDAd6/35++ - A new helper-dependent adenovirus vector platform for in vivo transduction of hematopoietic stem cells by Hongjie Wang, Aphrodite Georgakopoulou, Wenli Zhang, Jiho Kim, Sucheol Gil, Anja Ehrhardt, André Lieber
Published in Molecular Therapy: Methods & Clinical Development (2023-06-01)Get full text
Article -
5
-
6
-
7
-
8
Binding Mechanism Elucidation of the Acute Respiratory Disease Causing Agent Adenovirus of Serotype 7 to Desmoglein-2 by Marc-André Hograindleur, Gregory Effantin, Daphna Fenel, Caroline Mas, André Lieber, Guy Schoehn, Pascal Fender, Emilie Vassal-Stermann
Published in Viruses (2020-09-01)Get full text
Article -
9
CryoEM structure of adenovirus type 3 fibre with desmoglein 2 shows an unusual mode of receptor engagement by Emilie Vassal-Stermann, Gregory Effantin, Chloe Zubieta, Wim Burmeister, Frédéric Iseni, Hongjie Wang, André Lieber, Guy Schoehn, Pascal Fender
Published in Nature Communications (2019-03-01)Get full text
Article -
10
Two types of functionally distinct fiber containing structural protein complexes are produced during infection of adenovirus serotype 5. by Bo Zhang, Yuhua Yan, Jie Jin, Hongyu Lin, Zongyi Li, Xiaoyan Zhang, Jin Liu, Chao Xi, Andre Lieber, Xiaolong Fan, Liang Ran
Published in PLoS ONE (2015-01-01)Get full text
Article -
11
Properties of Adenovirus Vectors with Increased Affinity to DSG2 and the Potential Benefits of Oncolytic Approaches and Gene Therapy by Nora A. Bahlmann, Raphael L. Tsoukas, Sebastian Erkens, Hongjie Wang, Franziska Jönsson, Malik Aydin, Ella A. Naumova, André Lieber, Anja Ehrhardt, Wenli Zhang
Published in Viruses (2022-08-01)Get full text
Article -
12
Junction opener enables CAR T cell treatment of solid tumors by Steven J. Reed, Shibbu Sharma, Carrie Novák, Jiho Kim, Kaman Kim, Erene Niemi, Nicholas Korjeff, André Lieber, Steven G. Reed, Malcolm S. Duthie, Darrick Carter
Published in Scientific Reports (2026-03-01)Get full text
Article -
13
Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy by Sadia Zafar, Suvi Parviainen, Mikko Siurala, Otto Hemminki, Riikka Havunen, Siri Tähtinen, Simona Bramante, Lotta Vassilev, Hongjie Wang, Andre Lieber, Silvio Hemmi, Tanja de Gruijl, Anna Kanerva, Akseli Hemminki
Published in OncoImmunology (2017-02-01)Get full text
Article -
14
Correction: Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity. by Robert Strauss, Zong-Yi Li, Ying Liu, Ines Beyer, Jonas Persson, Pavel Sova, Thomas Möller, Sari Pesonen, Akseli Hemminki, Petra Hamerlik, Charles Drescher, Nicole Urban, Jiri Bartek, André Lieber
Published in PLoS ONE (2011-01-01)Get full text
Article -
15
Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeutic by Maximilian Richter, Roma Yumul, Kamola Saydaminova, Hongjie Wang, Michael Gough, Audrey Baldessari, Roberto Cattaneo, Frank Lee, Chung-Huei Katherine Wang, Haishan Jang, Anne Astier, Ajay Gopal, Darrick Carter, André Lieber
Published in Molecular Therapy: Methods & Clinical Development (2016-01-01)Get full text
Article -
16
In vivo base editing by a single i.v. vector injection for treatment of hemoglobinopathies by Chang Li, Aphrodite Georgakopoulou, Gregory A. Newby, Kelcee A. Everette, Evangelos Nizamis, Kiriaki Paschoudi, Efthymia Vlachaki, Sucheol Gil, Anna K. Anderson, Theodore Koob, Lishan Huang, Hongjie Wang, Hans-Peter Kiem, David R. Liu, Evangelia Yannaki, André Lieber
Published in JCI Insight (2022-10-01)Get full text
Article
